Smither John W
CIK: 0001559583•Chief Financial Officer
OfficerDirector
Primary company: KYTHERA BIOPHARMACEUTICALS INC (KYTH)
Smither John W is a corporate insider (Chief Financial Officer) at KYTHERA BIOPHARMACEUTICALS INC (KYTH) filing SEC Form 4 transactions. 189 transactions across 9 companies, totaling $0 in purchases and $8,633,069 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
GENELUX Corp GNLX | Award | 31,566 | $3.03 | $96K | 31,566 | 6/16/2026 Filed: 6/16/2026 | Filing → |
GENELUX Corp GNLX | Award | 28,409 | - | - | 103,403 | 6/16/2026 Filed: 6/16/2026 | Filing → |
GENELUX Corp GNLX | Award | 28,576 | - | - | 28,576 | 8/27/2025 Filed: 8/29/2025 | Filing → |
GENELUX Corp GNLX | Award | 22,283 | - | - | 74,994 | 8/27/2025 Filed: 8/29/2025 | Filing → |
NewAmsterdam Pharma Co N.V. NAMS | Award | 6,960 | - | - | 6,960 | 1/7/2025 Filed: 1/8/2025 | Filing → |
NewAmsterdam Pharma Co N.V. NAMS | Award | 32,500 | $25.85 | $840K | 32,500 | 1/6/2025 Filed: 1/8/2025 | Filing → |
GENELUX Corp GNLX | Award | 50,469 | - | - | 50,469 | 8/1/2024 Filed: 12/31/2024 | Filing → |
GENELUX Corp GNLX | Award | 50,469 | - | - | 50,469 | 8/1/2024 Filed: 8/5/2024 | Filing → |
GENELUX Corp GNLX | Award | 39,541 | - | - | 52,711 | 8/1/2024 Filed: 8/5/2024 | Filing → |
GENELUX Corp GNLX | Purchase | 6,250 | - | - | 6,250 | 5/29/2024 Filed: 6/7/2024 | Filing → |
GENELUX Corp GNLX | Purchase | 6,250 | - | - | 13,170 | 5/29/2024 Filed: 6/7/2024 | Filing → |
| Disposition | 25,718 | - | - | 0 | 2/13/2024 Filed: 2/15/2024 | Filing → | |
| Disposition | 8,379 | - | - | 0 | 2/13/2024 Filed: 2/15/2024 | Filing → | |
| Award | 8,572 | - | - | 11,365 | 2/13/2024 Filed: 2/15/2024 | Filing → | |
| Award | 2,793 | - | - | 2,793 | 2/13/2024 Filed: 2/15/2024 | Filing → | |
NewAmsterdam Pharma Co N.V. NAMS | Award | 10,000 | - | - | 10,000 | 1/1/2024 Filed: 1/3/2024 | Filing → |
Applied Molecular Transport Inc. AMTI | Disposition | 20,000 | $0.00 | $0 | 0 | 12/27/2023 Filed: 12/28/2023 | Filing → |
Applied Molecular Transport Inc. AMTI | Disposition | 60,000 | $0.00 | $0 | 0 | 12/27/2023 Filed: 12/28/2023 | Filing → |
Applied Molecular Transport Inc. AMTI | Disposition | 20,000 | $0.00 | $0 | 0 | 5/24/2022 Filed: 12/28/2023 | Filing → |
GENELUX Corp GNLX | Sale | 900 | $20.78 | $19K | 6,920 | 9/13/2023 Filed: 9/14/2023 | Filing → |
GENELUX Corp
GNLX
Type
Award
Shares
31,566
Price
$3.03
Value
$96K
GENELUX Corp
GNLX
Type
Award
Shares
28,409
Price
-
Value
-
GENELUX Corp
GNLX
Type
Award
Shares
28,576
Price
-
Value
-
GENELUX Corp
GNLX
Type
Award
Shares
22,283
Price
-
Value
-
NewAmsterdam Pharma Co N.V.
NAMS
Type
Award
Shares
6,960
Price
-
Value
-
NewAmsterdam Pharma Co N.V.
NAMS
Type
Award
Shares
32,500
Price
$25.85
Value
$840K
GENELUX Corp
GNLX
Type
Award
Shares
50,469
Price
-
Value
-
GENELUX Corp
GNLX
Type
Award
Shares
50,469
Price
-
Value
-
GENELUX Corp
GNLX
Type
Award
Shares
39,541
Price
-
Value
-
GENELUX Corp
GNLX
Type
Purchase
Shares
6,250
Price
-
Value
-
GENELUX Corp
GNLX
Type
Purchase
Shares
6,250
Price
-
Value
-
Type
Disposition
Shares
25,718
Price
-
Value
-
Type
Disposition
Shares
8,379
Price
-
Value
-
Type
Award
Shares
8,572
Price
-
Value
-
Type
Award
Shares
2,793
Price
-
Value
-
NewAmsterdam Pharma Co N.V.
NAMS
Type
Award
Shares
10,000
Price
-
Value
-
Applied Molecular Transport Inc.
AMTI
Type
Disposition
Shares
20,000
Price
$0.00
Value
$0
Applied Molecular Transport Inc.
AMTI
Type
Disposition
Shares
60,000
Price
$0.00
Value
$0
Applied Molecular Transport Inc.
AMTI
Type
Disposition
Shares
20,000
Price
$0.00
Value
$0
GENELUX Corp
GNLX
Type
Sale
Shares
900
Price
$20.78
Value
$19K
AI Agent
Try asking...